Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Gail_Maderis
|
| gptkbp:clinicalStage |
clinical-stage company
|
| gptkbp:developedBy |
topical therapeutics for HPV
|
| gptkbp:focusesOn |
antiviral therapeutics
treatment of HPV-related diseases |
| gptkbp:foundedYear |
2012
|
| gptkbp:founder |
gptkb:Karl_Hostetler
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Antiva Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Sofinnova_Ventures
gptkb:Osage_University_Partners gptkb:Canaan_Partners gptkb:Advent_Life_Sciences gptkb:Lumira_Ventures |
| gptkbp:products |
antiviral drugs for HPV-related pre-cancerous lesions
|
| gptkbp:website |
https://www.antivabio.com/
|
| gptkbp:bfsParent |
gptkb:Bahija_Jallal
gptkb:Wende_Hutton |
| gptkbp:bfsLayer |
7
|